Literature DB >> 20498398

Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?

Kimmie Ng, Deborah Schrag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20498398     DOI： 10.1200/JCO.2010.28.9314

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  Gene expression variations in microsatellite stable and unstable colon cancer cells.

Authors:  Marjun P Duldulao; Wendy Lee; Maithao Le; Zhenbin Chen; Wenyan Li; Jinhui Wang; Harry Gao; Haiquing Li; Joseph Kim; Julio Garcia-Aguilar
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

2.  High-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer.

Authors:  Srdjan Markovic; Jadranka Antic; Neda Dragicevic; Richard Hamelin; Zoran Krivokapic
Journal:  J Mol Histol       Date:  2012-01-01       Impact factor: 2.611

Review 3.  Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition.

Authors:  Manny D Bacolod; Francis Barany
Journal:  Ann Surg Oncol       Date:  2011-02-24       Impact factor: 5.344

4.  Multiple localized metachronous recurrences in a patient of colon cancer and therapeutic controversies in stage II colon cancer.

Authors:  Vijai Simha; Rakesh Kapoor; Saniya Sharma
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-18

5.  Adenoma-like adenocarcinoma: a subtype of colorectal carcinoma with good prognosis, deceptive appearance on biopsy and frequent KRAS mutation.

Authors:  Raul S Gonzalez; Justin M M Cates; Mary Kay Washington; Robert Daniel Beauchamp; Robert J Coffey; Chanjuan Shi
Journal:  Histopathology       Date:  2015-06-04       Impact factor: 5.087

6.  Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.

Authors:  Patrick G Gavin; Linda H Colangelo; Debora Fumagalli; Noriko Tanaka; Matthew Y Remillard; Greg Yothers; Chungyeul Kim; Yusuke Taniyama; Seung Il Kim; Hyun Joo Choi; Nicole L Blackmon; Corey Lipchik; Nicholas J Petrelli; Michael J O'Connell; Norman Wolmark; Soonmyung Paik; Kay L Pogue-Geile
Journal:  Clin Cancer Res       Date:  2012-10-08       Impact factor: 12.531

Review 7.  Chemotherapy for Stage II Colon Cancer.

Authors:  Anna Varghese
Journal:  Clin Colon Rectal Surg       Date:  2015-12

Review 8.  Prognostic and predictive significance of MSI in stages II/III colon cancer.

Authors:  Zacharenia Saridaki; John Souglakos; Vassilis Georgoulias
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  Review of histopathological and molecular prognostic features in colorectal cancer.

Authors:  Ola Marzouk; John Schofield
Journal:  Cancers (Basel)       Date:  2011-06-23       Impact factor: 6.639

10.  Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.

Authors:  Robert N Jorissen; Michael Christie; Dmitri Mouradov; Anuratha Sakthianandeswaren; Shan Li; Christopher Love; Zheng-Zhou Xu; Peter L Molloy; Ian T Jones; Stephen McLaughlin; Robyn L Ward; Nicholas J Hawkins; Andrew R Ruszkiewicz; James Moore; Antony W Burgess; Dana Busam; Qi Zhao; Robert L Strausberg; Lara Lipton; Jayesh Desai; Peter Gibbs; Oliver M Sieber
Journal:  Br J Cancer       Date:  2015-08-25       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.